TY - JOUR
AU - Song, Yexun
AB - INTRODUCTIONLaryngeal cancer is the second most common cancer among head and neck cancers, which affects a variety of anatomic subsites, including the oral cavity, oropharynx, nasopharynx, hypopharynx, larynx, paranasal sinuses and salivary glands (Lydiatt et al., 2017; Siegel et al., 2018). Based on the International Agency for Research on Cancer, there were approximately 177,422 new cases and 94,771 deaths from laryngeal cancer worldwide in 2018 (Bray et al., 2018). Although the diagnosis and treatment of laryngeal cancer has improved, the 5‐year survival rate has not significantly increased (Wolf et al., 2017). Thus, laryngeal cancer development will cause immense clinical, health and economic burdens that must be considered.Understanding the epidemiology of laryngeal cancer among different regions, nations and change trends is crucial for prevention, early diagnosis and treatment. Moreover, tracking the trend in laryngeal cancer over time is crucial to allocate resources, to set priorities and to evaluate the response of a given population to various health policies by physicians and policy makers. The Global Burden of Disease, Injuries and Risk Factors (GBD) study works on estimating the health loss due to all diseases since 1990.To the best of our knowledge, this is the first to investigate the global burden from 1990 to 2019 
TI - The global, regional, national burden of laryngeal cancer and its attributable risk factors (1990–2019) and predictions to 2035
JO - European Journal of Cancer Care
DO - 10.1111/ecc.13689
DA - 2022-11-01
UR - https://www.deepdyve.com/lp/wiley/the-global-regional-national-burden-of-laryngeal-cancer-and-its-WMYMpvHeyW
VL - 31
IS - 6
DP - DeepDyve
ER -